Complex Posterior reversible encephalopathy syndrome with ACA infarct a woman with Lupus: Case Repor and Review

Kevin Llano Almario; Gustavo Aroca Martinez; Lisette Iriarte Diaz; Zulay Mondol Almeida; Jhonny Llinas Rincon; Maria Raad Sarabia; Lourdes Carolina  Vázquez Jiménez; Jorge Rico Fontalvo

doi:10.18004/rpr/2023.09.01.33

Kevin Llano Almario Universidad del Sinu, Department of Internal Medicine, Cartagena, Bolívar, Colombia http://orcid.org/0000-0002-6315-3114
Gustavo Aroca Martinez Clínica de la Costa, Department of Nephrology, Barranquilla, Atlántico, Colombia http://orcid.org/0000-0002-9222-3257
Lisette Iriarte Diaz Universidad Libre, Department of Medicine, Barranquilla, Atlántico, Colombia http://orcid.org/0009-0006-6386-6495
Zulay Mondol Almeida Universidad del Sinu, Department of Internal Medicine, Cartagena, Bolívar, Colombia http://orcid.org/0000-0002-0469-6821
Jhonny Llinas Rincon Universidad Simón Bolívar, Department of Medicine, Cartagena, Bolívar, Colombia http://orcid.org/0009-0000-9856-1815
Maria Raad Sarabia Universidad del Sinu, Department of Internal Medicine, Cartagena, Bolívar, Colombia http://orcid.org/0000-0002-7080-7024
Lourdes Carolina Vázquez Jiménez Universidad Nacional de Asunción, Faculty of Medical Sciences, Department of Nephrology, San Lorenzo, Paraguay http://orcid.org/0000-0003-1416-552X
Jorge Rico Fontalvo Colombian Association of Nephrology and HTA, Kidney, Diabetes and Metabolism Committee, Bogotá, Colombia http://orcid.org/0000-0002-2852-1241

DOI: https://doi.org/10.18004/rpr/2023.09.01.33

Keywords: PRES, Encephalopathy, Rituximab, Sistemic lupus erythematous

Abstract

Posterior reversible encephalopathy syndrome is a clinical–radiological disorder, which usually progresses with classical acute neurological symptoms (visual impairment, acute headache, altered level of consciousness, seizures, and even focal neurological deficit). A case presented with a review of the currently available literature is reported in this article.

Downloads

Download data is not yet available.

References

(1) HINCHEY J, CHAVES C, APPIGNANI B, BREEN J, PAO L, WANG A, et al. A reversible posterior leukoencephalopathy syndrome. New England Journal of Medicine. 1996;38(334):494-500.

(2) Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions. The Lancet Neurology. 2015;14(9):914-25.

(3) Bartynski WS. Posterior reversible encephalopathy syndrome, Part 2: Controversies surrounding pathophysiology of vasogenic edema. American Journal of Neuroradiology. 2008;29(6):1043-9.

(4) McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, Santa Cruz KS, et al. Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. American Journal of Roentgenology. 2007;189(4):904-12.

(5) Grillo-Ardila MC, Martínez-Velásquez MY, Grillo-Ardila CF. Síndrome de encefalopatía posterior reversible ( PRES ) durante la gestación. Posterior reversible encephalopathy syndrome ( PRES ) during pregnancy. Acta Neurol Colomb. 2010;26(4):202-9.

(6) Schwartz RB, Jones KM, Kalina P et al. Encefalopatía hipertensiva: hallazgos en TC, RM y SPECT en 14 casos. AJR am roentgenol. 1992;159(2):379-83.

(7) Zuber M, Touzé E, Domigo V, Trystram D, Lamy C, Mas JL. Reversible cerebral angiopathy: Efficacy of nimodipine. Journal of Neurology. 2006;253(12):1585-8.

(8) Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Annals of the Rheumatic Diseases. 2001;60(5):534-7.

(9) Domínguez-Fuentes B, García-Gil D, Romero-Palacios A, Sánchez- Crespo JM, García-Arjona R, Navarro-Navarro J. Leucoencefalo- patía posterior reversible en una paciente con eclampsia posparto. Medicina Intensiva. 2008;32(7):361-3.

(10) Yamada A, Atsumi M, Tashiro A, Hiraiwa T, Ueda N. Recurrent posterior reversible encephalopathy syndrome in nephrotic syndrome: case report and review of the literature. Clin nephrol. 2012;78(5):406-11.

(11) Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clinic Pro- ceedings.2010;85(5):427-32.

(12) Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoence- phalopathy syndrome: a misnomer reviewed. internal medicine journal. 2005;3(Table 1):83-90.

(13) Magnano MD, Bush TM, Herrera I, Altman RD. Reversible Posterior Leukoencephalopathy in Patients with Systemic Lupus Erythemato- sus. Seminars in Arthritis and Rheumatism. 2006;35(6):396-402.

(14) Pirola JP, Baenas DF, Haye Salinas MJ, Benzaquén NR, Colazo M, Borghi MV, et al. Posterior reversible leukoencephalopathy syndrome: Case series and review of the literature. Reumatologia Clinica. 2020;16(2P2):169-73.

(15) S Mondal, R Prosad Goswami, D Sinha, K Basu, S Das, P Ghosh AG. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender. Lupus. 2015;(0):1-2.

(16) Siddiqi AI. Rituximab as a possible cause of posterior reversible encephalopathy syndrome. Australasian Medical Journal. 2011;4(9):513-5.

(17) Sanchez-Carteyron A, Alarcia R, Ara JR, Martín J. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AFTER RITUXIMAB INFUSION IN NEUROMYELITIS OPTICA. Neurology. 2010; 74(18):1471-5.

(18) Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leuco- encephalopathy syndrome after rituximab infusion. Rheumatology. 2004;43(11):1450-1.

(19) K Saito, M Nawata, S Nakayamada, M Tokunaga, J Tsukada YT. Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythe- matosus with renal and central nervous system involvement. Lupus. 2003;12(1):798-800.

(20) Silva-Sieger FA, Salas-Guerra AJ, Guerrero Gómez CF, Castellanos- Prada JA. Encefalopatía posterior reversible recurrente: reporte de caso. Revista Mexicana de Neurociencia. 2017;18(3):88-95.

(21) Algahtani H, Algahtani A, Aldarmahi A, Hmoud M, Marzuk Y, Shirah

(22) B. Posterior Reversible Encephalopathy Syndrome: Local Experience From Saudi Arabia. The Neurohospitalist. 2017;7(1):24-9.

(23) Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encepha- lopathy syndrome: The retrospective Berlin PRES study. Journal of Neurology. 2012;259(1):155-64.

(24) Ni J, Zhou LX, Hao H lin, Liu Q, Yao M, Li M li, et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: A retrospective series of 24 patients. Journal of Neuro- imaging. 2011;21(3):219-24.

(25) Liman TG, Bohner G, Endres M, Siebert E. Discharge status and in-hospital mortality in posterior reversible encephalopathy syndro- me. Acta Neurologica Scandinavica. 2014;130(1):34-9.

(26) LC Vázquez, Troya Saborido MI, Bancu IE, Bonet Sol J. Síndrome de encefalopatía posterior reversible y enfermedad renal crónica. A propósito de siete casos clínicos y revisión de la bibliografía. Nefro Plus 2016;8:7-13.